SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB

                                   (Mark One)

[X]QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
                                   ACT OF 1934

                   For the quarterly period ended May 31, 2003

                                       OR

   [ ]TRANSITION REPORT UNDER SECTION 13 OF 15(D) OF THE EXCHANGE ACT OF 1934

          From the transition period from             to
                                          -----------    ------------

                         Commission File Number 0-29439
                                                -------


                            TWISTEE TREAT CORPORATION
                            -------------------------
        (Exact name of small business issuer as specified in its charter)

                               Delaware 43-1796315
                               -------------------
    (State or other jurisdiction of incorporation or organization)(IRS Employer
                               Identification No.)


                 2983 Ravenswood Rd., Fort Lauderdale, FL 33312
                 ----------------------------------------------
                    (Address of principal executive offices)

                                  (877) 667-9377
                                  --------------
                           (Issuer's telephone number)

                                      N/A
                                      ---
   (Former name, former address and former fiscal year, if changed since last
                                    report)

     Indicate by check mark whether the registrant (1) filed all reports
required to be filed by Section 13 or 15(d) of the Exchange Act during the past
12 months (or for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements for the past
90 days:

                                   Yes: X       No:
                                       ---

As of July 18, 2003 5,607,797 shares of Common Stock of the issuer were
outstanding.

<PAGE>

                                     TWISTEE TREAT CORPORATION
                                            FORM 10-QSB

<TABLE>
<CAPTION>


                                                INDEX


                                                PART I
<S>      <C>                                                                                    <C>
Item 1.  Financial Statements                                                                   F-3

Item 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations  F-7


                                                PART II

Item 1.  Legal Proceedings                                                                      F-9

Item 6.  Exhibits and Reports on Form 8-K                                                       F-10

         Signatures                                                                             F-10
</TABLE>

<PAGE>

                         PART I.  FINANCIAL INFORMATION
<TABLE>
<CAPTION>

ITEM 1.  FINANCIAL STATEMENTS

                              TWISTEE TREAT CORPORATION
                                    BALANCE SHEETS

                                                              MAY 31,     NOVEMBER 30,
                                                               2003          2002
                                                           ------------  ------------
                                                           (UNAUDITED)
<S>                                                        <C>           <C>
ASSETS

Current assets:
  Cash                                                     $     5,433   $    15,962
                                                           ------------  ------------
    Total current assets                                         5,433        15,962

Property and equipment, net                                     78,394        92,290
                                                           ------------  ------------
                                                           $    83,827   $   108,252
                                                           ============  ============


LIABILITIES AND STOCKHOLDERS' DEFICIT

Current liabilities:
  Accounts payable                                         $   188,121   $   195,369
  Notes payable - shareholders                                  20,000        20,000
                                                           ------------  ------------
    Total current liabilities                                  208,121       215,369
                                                           ------------  ------------

Stockholders' deficit:
  Preferred stock, $.0001 par value, 10,000,000 shares
    authorized, none issued and outstanding
  Common stock, $.0001 par value, 50,000,000 shares                561           301
    authorized, 5,607,797 and 3,007,795 shares issued and
    outstanding
  Additional paid-in capital                                 3,840,474     3,747,774
  Accumulated deficit                                       (3,865,329)   (3,755,192)
                                                           ------------  ------------
                                                               (24,294)       (7,117)
  Less: subscriptions receivable                              (100,000)     (100,000)
                                                           ------------  ------------
    Total stockholders' deficit                               (124,294)     (107,117)
                                                           ------------  ------------
                                                           $    83,827   $   108,252
                                                           ============  ============
</TABLE>

<PAGE>

<TABLE>
<CAPTION>

                                TWISTEE TREAT CORPORATION
                                STATEMENTS OF OPERATIONS
                                       (UNAUDITED)

                                         THREE MONTHS ENDED         SIX MONTHS ENDED
                                               MAY 31,                  MAY 31,
                                         2003         2002         2003         2002
                                      -----------  -----------  -----------  -----------
<S>                                   <C>          <C>          <C>          <C>
Net sales                             $        -   $        -   $        -   $        -
Cost of sales                                  -            -            -            -
                                      -----------  -----------  -----------  -----------
Gross profit                                   -            -            -            -

Operating expenses:
  Payroll and contractual expense         20,000            -       44,855       41,666
  Depreciation and amortization            6,948        6,947       13,896       13,895
    expense
  Consulting expense                       9,600            -       43,800            -
  Legal and professional fees              2,000       39,946        2,000       45,946
  Other general and administrative         2,546        8,009        5,586       18,926
                                      -----------  -----------  -----------  -----------
                                          41,094       54,902      110,137      120,433
                                      -----------  -----------  -----------  -----------

Loss from operations                     (41,094)     (54,902)    (110,137)    (120,433)

Other income (expense)
  Interest expense                             -       (5,745)           -      (10,727)
  Other income                                 -        2,433            -        2,433
                                      -----------  -----------  -----------  -----------
                                               -       (3,312)           -       (8,294)
                                      -----------  -----------  -----------  -----------

Net loss                              $  (41,094)  $  (58,214)  $ (110,137)  $ (128,727)
                                      ===========  ===========  ===========  ===========

Basic and diluted loss per common     $    (0.01)  $    (0.02)  $    (0.03)  $    (0.06)
                                      ===========  ===========  ===========  ===========
  share

Weighted average shares outstanding    5,009,969    2,490,186    4,136,916    2,292,465
                                      ===========  ===========  ===========  ===========
</TABLE>

<PAGE>

<TABLE>
<CAPTION>


                            TWISTEE TREAT CORPORATION
                            STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)


                                                         SIX MONTHS ENDED
                                                              MAY 31,
                                                         2003        2002
                                                      ----------  ----------
<S>                                                   <C>         <C>
Cash flows from operating activities:
  Net loss                                            $(110,137)  $(128,727)
    Adjustments to reconcile net income to net cash
      used in operating activities:
    Depreciation and amortization                        13,896      13,895
  Changes in operating assets and liabilities
    Notes and other receivables                                         (62)
    Accounts payable and accrued expenses                (7,248)     49,095
                                                      ----------  ----------
        Net used in operating activities               (103,489)    (65,799)
                                                      ----------  ----------

Cash flows from financing activities:
  Payments on notes payable                                   -      (6,483)
  Proceeds from sale of common stock                     92,960      76,000
                                                      ----------  ----------
        Net cash provided by financing activities        92,960      69,517
                                                      ----------  ----------

Net increase (decrease) in cash and cash equivalents    (10,529)      3,718
Cash and cash equivalents at beginning of period         15,962       2,322
                                                      ----------  ----------
Cash and cash equivalents at end of period            $   5,433   $   6,040
                                                      ==========  ==========

Cash paid for:
  Interest                                            $       -   $       -
                                                      ==========  ==========
</TABLE>

<PAGE>

                            TWISTEE TREAT CORPORATION
                      NOTES TO INTERIM FINANCIAL STATEMENTS
                                FEBRUARY 28, 2003


Note 1:Presentation

The balance sheet of the Company as of May 31, 2003, the related statements of
operations for the three and six months ended May 31, 2003 and 2002 and the
statements of cash flows for the six months ended May 31, 2003 and 2002 included
in the financial statements have been prepared by the Company without audit.  In
the opinion of management, the accompanying financial statements include all
adjustments (consisting of normal, recurring adjustments) necessary to summarize
fairly the Company's financial position and results of operations.  The results
of operations for the three and six months ended May 31, 2003 are not
necessarily indicative of the results of operations for the full year or any
other interim period.  The information included in this Form 10-QSB should be
read in conjunction with Management's Discussion and Analysis and Financial
Statements and notes thereto included in the Twistee Treat Corporation's
November 30, 2002 Form 10-KSB.

<PAGE>

ITEM  2.  MANAGEMENT'S  DISCUSSION  AND  ANALYSIS

THIS  REPORT  CONTAINS  FORWARD LOOKING STATEMENTS WITHIN THE MEANING OF SECTION
27A  OF THE SECURITIES ACT OF 1933, AS AMENDED AND SECTION 21E OF THE SECURITIES
EXCHANGE  ACT  OF  1934,  AS  AMENDED. THE COMPANY'S ACTUAL RESULTS COULD DIFFER
MATERIALLY FROM THOSE SET FORTH ON THE FORWARD LOOKING STATEMENTS AS A RESULT OF
THE  RISKS  SET  FORTH IN THE COMPANY'S FILINGS WITH THE SECURITIES AND EXCHANGE
COMMISSION,  GENERAL ECONOMIC CONDITIONS, AND CHANGES IN THE ASSUMPTIONS USED IN
MAKING  SUCH  FORWARD  LOOKING  STATEMENTS.

GENERAL  OVERVIEW

Overview.

Twistee Treat operated and franchised soft-serve ice cream desserts and an
assortment of other foods and beverages in its proprietary, cone-shaped
buildings and kiosks.  Incorporated in Missouri in 1997, we redomiciled by
merger into a Delaware corporation in June of 1999 with the name Twistee Treat
Corporation.  On April 6, 2000, we purchased a publicly-reporting Nevada
corporation, Perfection Plus, Inc., as described more fully in our Form 8-K
filed with the Securities and Exchange Commission on April 8, 2000, and as
subsequently amended.  During the three months ended February 30, 2003, the
Company did not have any operations and had three inactive franchises.

RESULTS  OF  OPERATIONS

THREE MONTHS AND SIX MONTHS ENDED MAY 31, 2003 COMPARED TO THREE MONTHS AND SIX
MONTHS ENDED MAY 31, 2002

There were no net sales for the three and six months ended February 28, 2003 and
2002,  respectively.  Twistee  is  pursuing  strategic  partners  or  merger
candidates.

Operating expenses for the three months ended May 31, 2003 decreased by $13,808
or 25% to $41,094 from $54,902 for the corresponding period of the prior year.
The decrease is attributable to the Company replacing its President and reducing
salaries as well as a reduction of legal and professional fees.

For the six month period ending May 31, 2003 operating expenses decreased
$10,296 or 9% to $110,137 from $120,433 for the corresponding period of the
prior year. The decrease is attributable to a decrease in consulting,
professional fees and other general expenses.

Net loss for the three months ended May 31, 2003 decreased by $17,120 to a loss
of $41,094 from a loss of $58,214 for the corresponding period of the prior
year.  For the three months ended May 31, 2003 and 2002 the Company did not
record a tax benefit.

For the six months ended May 31, 2003, the net loss decreased $18,590 to a loss
of $110,137 from a net loss of $128,727 for the corresponding period of the
previous year.  The Company's did not record a tax benefit for the six months
ended May 31, 2003 and 2002.

<PAGE>

LIQUIDITY AND CAPITAL RESOURCES

At February 28, 2003, the Company had negative working capital of $202,688.

Net cash provided by financing activities increased to $92,960 from $69,517.
The Company received $92,960 from the sale of its common stock for the six
months ended May 31, 2003.  The Company utilized those proceeds to pay current
expenses.

The Company has no credit line or other bank debt, and has generated its cash
from the sale of its common stock.  At May 31, 2003, the Company had a
stockholders' deficit of $124,294, an increase of approximately 16% from the
$107,117 of stockholders' deficit existing at November 30, 2002.

As reflected in the accompanying financial statements and at May 31, 2003, the
Company has a working capital deficit of $202,688 and a net loss from operations
of $110,137 for the six months ended May 31, 2003.  The Company's operations are
not sufficient to finance its growth.  The ability of the Company to continue as
a going concern is dependent upon its ability to raise additional capital and
implement its business plan.  The Company anticipates issuing additional debt
and equity securities and reducing operating overhead.  Management believes that
actions presently taken to improve its future operations and obtain additional
funding provide the opportunity for the Company to continue as a going concern.

FACTORS THAT MAY AFFECT FUTURE RESULTS

Dependence Upon External Financing:  The Company has been building its business
through revenues generated from operations, supplemented by the sale of its
capital common stock.  The ability of the Company to continue to grow and expand
its business is highly dependent upon the ability of the Company to continue to
raise external financing, from the sale of equity and/or the incurrence of debt.
If the Company were unable to obtain debt and/or equity financing upon terms
that were sufficiently favorable to the Company, or at all, it would have a
materially adverse impact upon the ability of the Company to continue to expand
its business and operations, or to implement its business plan as now
contemplated by the Company.

Reliance on Key Management:  The success of the Company is highly dependent upon
the continued services of James A. Tilton, its Chief Financial Officer, who is
the primary person responsible for building the Company's renewed franchises,
regional development and licensing business.  If he were to leave the Company,
it could have a materially adverse effect upon the business and operations of
the Company.


OTHER INFORMATION

ITEM 1: Legal Proceedings

The  Company has a dispute with a law firm regarding past due fees. The law firm
Feldhake,  August  &  Roquemore  LLP  received a default judgment for $16,349.94
composed  of  principal  and  interest  on May 28, 2002 in the Superior Court of
California,  County  of  Orange  styled  as  case  number  01HL04797.

<PAGE>

The  Company  filed  a  lawsuit on February 5, 2003 against 3866955 Canada Inc.,
Liptok,  Inc.,  Twistee  Treat  Canada,  3585468  Canada, Inc., Andrew Evans and
Twisters  Ice Cream in the United States District Court in the Southern District
of Florida styled as cause number 03-60168. The Company is seeking a declaratory
judgment with respect to the sole and exclusive right to a trademark and service
mark  relating to a building design. Among the other causes of action brought by
the  Company  include the following: falsity and fraud in trademark application;
federal trademark infringement; trade dress infringement; unfair competition and
false  designation  of origin; common law trademark, trade name infringement and
unfair  competition;  and  domain  infringement.

ITEM  3.   CONTROLS  AND  PROCEDURES

Based  on  the evaluation of the Company's disclosure controls and procedures by
Mr.  James  A.  Tilton,  both  the  chief executive officer and chief accounting
officer  of  the company, as of a date within 90 days of the filing date of this
quarterly  report,  such  officer  has  concluded  that the Company's disclosure
controls  and  procedures are effective in ensuring that information required to
be  disclosed  by  the Company in the reports that it files or submits under the
Securities  and  Exchange  Act  of  1934,  as  amended,  is recorded, processed,
summarized  and reported, within the time period specified by the Securities and
Exchange  Commission's  rules  and  forms.

There were no significant changes in the Company's internal controls or in other
factors that could significantly affect these controls subsequent to the date of
their  evaluation,  including  any corrective actions with regard to significant
deficiencies  and  material  weaknesses.

<PAGE>

PART II - OTHER INFORMATION

Item 2.  Changes In Securities

During the quarter ended February 2003, Calder Investments, Ltd. acquired
2,000,000 shares of common stock for $0.03 per share.

During February 2003, Gordon Wilson, a director acquired 100,000 shares of
common stock for $0.03 per share.

During April 2003, Gordon Wilson, a director acquired 1,000,000 shares of common
stock for $0.03 per share.

Item 6.  EXHIBITS AND REPORTS ON FORM 8-K

     a)  Exhibits

     99.1     Certification of Chief Executive Officer and Chief Financial
Officer Pursuant to 18 U.S.C. Section
     1350

     b) Reports on Form 8-K

     None


                                      SIGNATURES

In  accordance  with  the  requirements  of the Exchange Act, the Registrant has
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

          TWISTEE  TREAT  CORPORATION

Dated:    July  18,  2003

          By:  /s/  JAMES  A.  TILTON
          -----------------------------------
          James  A.  Tilton  (President  and  Chief  Accounting  Officer)


<PAGE>

CERTIFICATION


I,  James  A.  Tilton,  certify  that:

     I  have  reviewed  this  quarterly  report  on Form 10-QSB of Twistee Treat
Corporation;

     Based  on  my  knowledge, this quarterly report does not contain any untrue
statement  of a material fact or omit to state a material fact necessary to make
the  statements  made, in light of the circumstances under which such statements
were  made,  not misleading with respect to the period covered by this quarterly
report;

     Based  on  my  knowledge,  the  financial  statements,  and other financial
information  included  in  this quarterly report, fairly present in all material
respects  the  financial  condition, results of operations and cash flows of the
registrant  as  of,  and  for,  the  periods presented in this quarterly report;

     The  registrant's  other  certifying  officers  and  I  are responsible for
establishing  and  maintaining disclosure controls and procedures (as defined in
Exchange  Act  Rules  13a-14  and  15d-14)  for  the  registrant  and  have:

a)     designed  such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is  made  known  to  us by others within those entities, particularly during the
period  in  which  this  quarterly  report  is  being  prepared;

b)     evaluated  the  effectiveness of the registrant's disclosure controls and
procedures  as  of  a  date  within  90  days  prior  to the filing date of this
quarterly  report  (the  "Evaluation  Date");  and

c)     presented  in  this  quarterly  report  our  conclusions  about  the
effectiveness  of the disclosure controls and procedures based on our evaluation
as  of  the  Evaluation  Date;


     The  registrant's  other certifying officers and I have disclosed, based on
our most recent evaluation, to the registrant's auditors and the audit committee
of  the  registrant's  board  of directors (or persons performing the equivalent
functions):

a)     all  significant  deficiencies  in  the  design  or operation of internal
controls  which  could  adversely  affect  the  registrant's  ability to record,
process,  summarize  and  report  financial  data  and  have  identified for the
registrant's  auditors  any  material  weaknesses  in  internal  controls;  and

b)     any  fraud,  whether  or  not material, that involves management or other
employees who have a significant role in the registrant's internal controls; and

     The  registrant's  other  certifying  officers and I have indicated in this
quarterly  report whether there were significant changes in internal controls or
in other factors that could significantly affect internal controls subsequent to
the  date  of  our most recent evaluation, including any corrective actions with
regard  to  significant  deficiencies  and  material  weaknesses.

Date:     July  18,  2003

          /s/  JAMES  A.  TILTON
          -----------------------------------------
         James  A.  Tilton,  President  and  Chief  Financial  Officer

<PAGE>